1037435-71-4Relevant academic research and scientific papers
Synthesis of oligo(spiroketal)s by polycondensation of silyl ethers derived from naturally occurring myo-inositol with 1,4-cyclohexanedione
Sudo, Atsushi,Yamasaki, Tomoki,Yamashita, Takuro,Ishida, Dai
, p. 2407 - 2414 (2019)
Oligo(spiroketal)s (OSKs) were synthesized from myo-inositol, a naturally occurring cyclic compound bearing six hydroxyl groups. The successful synthesis of OSKs was achieved using silyl ethers 2 derived from 1,4-di-O-alkylated myo-inositol 1 as monomers,
Tetrakisphosphates and Bispyrophosphates of myo-Inositol Derivatives as Allosteric Effectors of Human Hemoglobin: Synthesis, Molecular Recognition, and Oxygen Release
Koumbis, Alexandros E.,Duarte, Carolina D.,Nicolau, Claude,Lehn, Jean-Marie
, p. 169 - 180 (2013/01/09)
Various 2,5- and 1,4-substituted and unsubstituted myo-inositol tetrakisphosphates and bispyrophosphates were prepared following a general synthetic pathway. All final compounds were tested for their capability to induce oxygen release from human hemoglob
CYCLITOLS AND THEIR DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS
-
Page/Page column 33; 49-50, (2008/12/07)
The present invention is directed to polyphosphorylated and pyrophosphate derivatives of cyclitols. More particularly, the invention relates to polyphosphorylated and pyrophosphate derivatives of inositols. The invention also relates to compositions of the polyphosphorylated and pyrophosphate derivatives of inositol and other similar, more lipophilic derivatives, and their use as allosteric effectors, cell-signaling molecule analogs, and therapeutic agents.
